ArticleCancer medicine2023

Risk factors for the failure of first-line PARP inhibitor maintenance therapy in patients with advanced ovarian cancer: Gynecologic Oncology Research Investigators Collaboration Study (GORILLA-3004).

Nam Kyeong Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.